H
Harry C. Lowe
Researcher at Concord Repatriation General Hospital
Publications - 110
Citations - 2670
Harry C. Lowe is an academic researcher from Concord Repatriation General Hospital. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 23, co-authored 105 publications receiving 2375 citations. Previous affiliations of Harry C. Lowe include University of Sydney & Concord Hospital.
Papers
More filters
Journal ArticleDOI
In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients With Acute Coronary Syndrome by Intravascular Optical Coherence Tomography
Haibo Jia,Farhad Abtahian,Aaron D. Aguirre,Stephen M. S. Lee,Stanley Chia,Harry C. Lowe,Koji Kato,Taishi Yonetsu,Rocco Vergallo,Sining Hu,Sining Hu,Jinwei Tian,Jinwei Tian,Hang Lee,Seung-Jung Park,Yangsoo Jang,Owen Christopher Raffel,Kyoichi Mizuno,Shiro Uemura,Tomonori Itoh,Tsunekazu Kakuta,So-Yeon Choi,Harold L. Dauerman,Abhiram Prasad,Catalin Toma,Iris McNulty,Shaosong Zhang,Bo Yu,V Fuster,Jagat Narula,Renu Virmani,Ik-Kyung Jang +31 more
TL;DR: Optical coherence tomography is a promising modality for identifying OCT-erosion and OCT-CN in vivo in patients with acute coronary syndrome and is more common in older patients.
Journal ArticleDOI
New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
Fernando S. Santiago,Harry C. Lowe,Mary M. Kavurma,Colin N. Chesterman,Baker Andrew R,David Atkins,Levon M. Khachigian +6 more
TL;DR: ED5 cleaved this 23-nucleotide substrate (labeled with 32P at the 5′ end) within 10 minutes (Fig. 1b).
Journal ArticleDOI
Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.
Ravinay Bhindi,Roger G. Fahmy,Harry C. Lowe,Colin N. Chesterman,Crispin R. Dass,Murray J. Cairns,Edward G. Saravolac,Lun-Quan Sun,Levon M. Khachigian +8 more
TL;DR: This review tracks current movements in gene-silencing technologies, focusing mainly on DNA enzymes and short interfering RNA, because these are poised to play an integral role in antigene therapies in the future.
Journal ArticleDOI
Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study.
Lei Xing,Takumi Higuma,Zhao Wang,Aaron D. Aguirre,Kyoichi Mizuno,Masamichi Takano,Harold L. Dauerman,Seung-Jung Park,Yangsoo Jang,Chong Jin Kim,Soo Joong Kim,So-Yeon Choi,Tomonori Itoh,Shiro Uemura,Harry C. Lowe,Darren L. Walters,Peter Barlis,Stephen M. S. Lee,Amir Lerman,Catalin Toma,Jack Wei Chieh Tan,Erika Yamamoto,Krzysztof Bryniarski,Jiannan Dai,Thomas Zanchin,Shaosong Zhang,Bo Yu,Hang Lee,James G. Fujimoto,Valentin Fuster,Ik-Kyung Jang,Ik-Kyung Jang +31 more
TL;DR: The presence of LRP in the nonculprit regions of the target vessel by OCT predicts increased risk for future NC-MACE, which is primarily driven by revascularization for recurrent ischemia.
Journal ArticleDOI
Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve
Andy S.C. Yong,Austin C.C. Ng,David Brieger,Harry C. Lowe,Martin K.C. Ng,Leonard Kritharides +5 more
TL;DR: The accuracy of QCA in predicting functionally significant FFR is limited and is dependent on FFR cut-off used and lesion severity, and 3D-QCA showed a non-significant trend towards more accurate prediction of FFR than 2D- QCA, especially in intermediate lesions.